Considering Insulin Secretory Capacity as Measured by a Fasting C-Peptide/Glucose Ratio in Selecting Glucose-Lowering Medications

Type 2 diabetes mellitus is a heterogeneous disease. Recently introduced new subclassifications promise more efficacious, tailored treatments which could complement current guidelines. In the differentiation of the new diabetes subphenotypes, assessment of insulin secretion is one of the essential c...

Descripción completa

Detalles Bibliográficos
Autores principales: Fritsche, Andreas, Heni, Martin, Peter, Andreas, Gallwitz, Baptist, Kellerer, Monika, Birkenfeld, Andreas L., Häring, Hans-Ulrich, Wagner, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926455/
https://www.ncbi.nlm.nih.gov/pubmed/32947641
http://dx.doi.org/10.1055/a-1242-9809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926455/
https://www.ncbi.nlm.nih.gov/pubmed/32947641
http://dx.doi.org/10.1055/a-1242-9809

Ejemplares similares